SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062301
Filing Date
2019-11-12
Accepted
2019-11-12 10:50:46
Documents
51
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919584-1_10q.htm 10-Q 468691
2 EXHIBIT 31.1 tm1919584d1_ex31-1.htm EX-31.1 10662
3 EXHIBIT 31.2 tm1919584d1_ex31-2.htm EX-31.2 10619
4 EXHIBIT 32.1 tm1919584d1_ex32-1.htm EX-32.1 5251
5 EXHIBIT 99.1 tm1919584d1_ex99-1.htm EX-99.1 48213
12 GRAPHIC tm1919584-1_10qimg01.jpg GRAPHIC 11731
13 GRAPHIC tm1919584d1_ex99-1img01.jpg GRAPHIC 2275
  Complete submission text file 0001104659-19-062301.txt   3461476

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fencf-20190930.xml EX-101.INS 936254
7 XBRL TAXONOMY EXTENSION SCHEMA fencf-20190930.xsd EX-101.SCH 30411
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20190930_cal.xml EX-101.CAL 24031
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20190930_def.xml EX-101.DEF 92805
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20190930_lab.xml EX-101.LAB 204240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20190930_pre.xml EX-101.PRE 180171
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 191207061
SIC: 2836 Biological Products, (No Diagnostic Substances)